Factors Associated With Chemotherapy-Induced Vomiting Control in Pediatric Patients Receiving Moderately or Highly Emetogenic Chemotherapy: A Pooled Analysis

Study (n=735) noted that younger age, shorter acute-phase duration, and antiemetic regimen (ondansetron with aprepitant or fosaprepitant better than ondansetron alone) were linked to acute-phase complete chemotherapy-induced vomiting control in this patient population.


Journal of Clinical Oncology